Legal
Refine Search
Pharmaceutical
French pharma major Sanofi saw its shares fall 1% to 72.42 euros by late morning trading today, after it announced a deal with a US regulator over alleged bribery. 5 September 2018
Biotechnology
In response to a lawsuit filed against China Biologic Products in the Cayman Islands by David (Xiaoying) Gao, the former chairman and chief executive of the company who was terminated for cause, China Biologic stated: "We deeply regret that Mr. David Gao, acting individually in his personal capacity, has attempted to challenge the completion of the private placement that was announced on August 24. 28 August 2018
Biotechnology
An arbitration panel has found in favor of French diabetes specialist Adocia to resolve the first of its claims against US pharma major Eli Lilly. 21 August 2018
Biotechnology
Officials are facing swift action in China over a vaccine scandal that has hit stocks and risked undermining public confidence in healthcare in the country. 17 August 2018
Biotechnology
News of challenges to US biotech giant Gilead Sciences’ intellectual property in overseas markets is commonplace, with the company conceding patents relating to its hepatitis C drugs in China this week. 14 August 2018
Biotechnology
The USA-based non-profit campaigner on patents, I-MAK, has claimed a significant victory in its bid to bring hepatitis C treatments that were previously protected by patents to the world’s largest patient population. 14 August 2018
Pharmaceutical
Shares in the German life sciences giant Bayer fell by 11% over the weekend after a US court ruled that the weedkiller Roundup (glyphosate) was responsible for the cancer of a school janitor. 13 August 2018
Pharmaceutical
I-MAK, a pressure group composed of lawyers, health professionals and academics, has published a report excoriating pharma giants for allegedly exploiting patent laws in order to drive up prices. 7 August 2018
Generics
In a filing with the Securities and Exchange Commission, US neurological diseases specialist Acorda Therapeutics reported updates on its litigation with Netherlands-headquartered drugmaker Mylan and its affiliates, as well as other, relating to multiple sclerosis drug Ampyra (dalfampridine) Orange Book-listed patents. 6 August 2018
Pharmaceutical
In an Expert View piece, Doug Robinson, principal at IP firm Harness Dickey, considers some of the challenges facing the pharma industry in the field of patent rights. 3 August 2018
Generics
Last month, the Italian Antitrust Authority (ICA) closed the proceedings launched to verify South Africa-based Aspen Pharma’s (JSE: APN) compliance with its decision of September 2016, it was announced today. Aspen appealed the decision in October that year. 31 July 2018
Pharmaceutical
Netherlands-headquartered drugmaker Mylan has filed a challenge in New Delhi’s high court in response to the Indian government’s ban on oxytocin. 30 July 2018
Pharmaceutical
The General Data Protection Regulation (GDPR) came into force on May 25, 2018. In an Expert View piece, Christian Hebenstreit — general manager and senior vice president at Medidata Solutions — explores the ramifications that this far-reaching change to data regulation could have on the life sciences industry. 25 July 2018
Generics
Janssen Pharmaceuticals, part of US health care giant Johnson & Johnson, is considering initiating legal proceedings against Russian drugmaker Pharmsyntez for the registration of an analogue of an anti-HIV rilpivirine drug, the patent for which belongs to Janssen, reports The Pharma Letter’s local correspondent. 24 July 2018
Biosimilars
The biopharmaceutical unit of Korea’s Samsung group deliberately kept quiet on the option that US biotech Biogen had to increase its share in their joint venture focused on biosimilars. 13 July 2018
Pharmaceutical
After many years of litigation from cancer patients, a court in Missouri, USA, has ordered healthcare giant Johnson & Johnson to pay an eye-watering $4.7 billion in damages to 22 women who allege harm caused by products containing talc. 13 July 2018
Pharmaceutical
DUSA Pharmaceuticals has filed trade secret misappropriation and tortious interference claims in an ongoing patent infringement lawsuit against Germany-based skin cancer specialist Biofrontera and subsidiaries in the US District Court for the District of Massachusetts. 12 July 2018
Pharmaceutical
Purdue Pharmaceuticals has announced its decision to halt all marketing efforts for its opioid products — including the controversal Oxycontin (oxycodone) — in Canada. 6 July 2018
Pharmaceutical
Judy Lewent, a director at UK drugmaker GlaxoSmithKline and chair of its audit and risk committee, has been named as a defendant in a lawsuit filed by the state of Massachusetts over the opioid crisis. 4 July 2018
Pharmaceutical
In an Expert View piece, Andreas von Falck and Miriam Gundt, both partners at Hogan Lovells' global patent litigation practice, give an overview of the intellectual property landscape for drugmakers in Europe. 28 June 2018
Biotechnology
India’s Sun Pharma has been blocked in its efforts to launch its JAK inhibitor Leqselvi (deuruxolitinib) in the USA. 6 November 2024
article
The European Union's antitrust enforcer hit Israeli drugmaker Teva Pharmaceutical Industries (NYSE: TEVA) with a 463 million-euro ($502 million) fine Thursday for launching a smear campaign against a rival multiple sclerosis drug and misusing the patent system to thwart the competitor's attempt to entering the market. 31 October 2024
Biotechnology
UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 vaccine. 16 October 2024
Generics
Two US units of Israel’s Teva Pharmaceutical Industries have agreed to pay $450 million to resolve two matters that allege Teva violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA), the US Department of Justice (DoJ) announced yesterday. 11 October 2024
Pharmaceutical
GSK has reached a settlement with 10 plaintiff firms, resolving 93% of the Zantac (ranitidine) product liability cases it faced in state courts across the USA. 10 October 2024
Pharmaceutical
Cardiopulmonary diseases specialist Liquidia Corporation closed Monday’s trading 11% higher following a favorable court ruling. 8 October 2024
Generics
Novo Nordisk has reached a settlement with Mylan Pharmaceuticals, now part of Viatris, putting an end to a US patent lawsuit over blockbuster diabetes treatment Ozempic (semaglutide). 8 October 2024
Pharmaceutical
Texas Attorney General Ken Paxton has filed a lawsuit against major pharmaceutical companies, including Eli Lilly (NYSE: LLY), alleging a conspiracy to artificially inflate the prices of insulin by up to 1,000%. 7 October 2024
Biotechnology
Bristol Myers Squibb has scored a major legal victory as a judge in New York dismissed a $6.4 billion lawsuit related to its acquisition of cancer company Celgene. 5 October 2024
Pharmaceutical
The US Department of Health and Human Services (HHS) has released final guidance for the second cycle of Medicare drug price negotiations. 3 October 2024
Pharmaceutical
Texas-based Cassava Sciences was trading 13% lower in Friday’s pre-market trading. 27 September 2024
Pharmaceutical
The Pharmaceutical Research and Manufacturers of America (PhRMA) is continuing its legal challenge against the US government’s drug pricing reforms. 24 September 2024
Pharmaceutical
On Friday, the USA’s Federal Trade Commission (FTC) brought action against the three largest prescription drug benefit managers (PBMs) - Caremark Rx, Express Scripts (ESI), and OptumRx 23 September 2024
Pharmaceutical
In a lawsuit filed in federal court in Missouri, USA, Health insurer Cigna (NYSE: CI) and its pharmacy benefit manager (PBM) Express Scripts demanded that the Federal Trade Commission (FTC) retract its July 2024 report. 18 September 2024
Generics
Several pharma companies that had moved the Delhi High Court against the government’s recent notification banning 156 fixed-dose combination (FDC) drugs have got a breather. 10 September 2024
Generics
Glenmark Pharmaceuticals has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug, the US Department of Justice announced. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Biosimilars
Regeneron Pharmaceuticals has filed a lawsuit against Sandoz, alleging that its biosimilar to Eylea (aflibercept) infringes certain patents. 29 August 2024
Pharmaceutical
Ireland-headquartered Avadel Pharmaceuticals has updated on litigation with USA-based Jazz Pharmaceuticals. 29 August 2024
Pharmaceutical
Liquidia Corporation announced Thursday that it has filed litigation in the US District Court of the District of Columbia (Case No. 1:24-cv-02428) that challenges the recent decision by the US Food and Drug Administration (FDA) to grant three-year new clinical investigation (NCI) exclusivity to Tyvaso (treprostinil) DPI.9.6. 23 August 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze